MY CONTENT

A total of 408 patients from the ESCAPE-NA1 trial were assessed for hemorrhagic transformation following endovascular treatment. At 24-hour follow-up imaging, the authors found that larger “core” volumes of relative CBF<30% were associated with an increased risk of parenchymal hemorrhage. In conjunction with other clinical and imaging variables, this metric may help estimate the risk of post-endovascular treatment hemorrhagic complications.